Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: KVUE )

21.46 +0.14 (+0.66%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,513,047
Open 21.39
Bid (Size) 21.23 (3)
Ask (Size) 22.16 (1)
Prev. Close 21.32
Today's Range 21.31 - 21.51
52wk Range 17.67 - 23.55
Shares Outstanding N/A
Dividend Yield 0.93%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
All It Takes Is $1,000 Invested in Each of These 3 Dividend Kings to Help Generate Over $100 in Passive Income Per Year
Target, PepsiCo, and Kenvue have high yields and inexpensive valuations. 
Via The Motley Fool
Navigating 10 Analyst Ratings For Kenvue
Via Benzinga

Performance

YTD
-0.51%
-0.51%
1 Month
-8.25%
-8.25%
3 Month
+18.50%
+18.50%
6 Month
+12.18%
+12.18%
1 Year
+9.83%
+9.83%

More News

Read More
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
Via Benzinga
P/E Ratio Insights for Kenvue
Via Benzinga
There are signs that NYSE:KVUE may be ready to breakout.
Via Chartmill
Analyst Ratings For Kenvue
Via Benzinga
Decoding 5 Analyst Evaluations For Kenvue
Via Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Via Benzinga
Kenvue Drives Climate Action Strategy Forward
From Kenvue
Via Business Wire
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
Via Benzinga
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
Via The Motley Fool
Magnificent 7 Miss Out, 2 Cybersecurity Stocks Stand Firm, Retailers Lag In Volatile August: Here Are The Top S&P 500 Gainers And Losers
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Donald Trump Owns These 21 Dividend Kings. Should You?
Via The Motley Fool
Topics Government
Exposures Political
Kenvue Announces Participation in the Barclays Global Consumer Staples Conference
From Kenvue
Via Business Wire
A Big CEO Move, Big Buffett Buys, and More
Via The Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
Via The Motley Fool
Topics ETFs
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
7 Stable Dividend Stocks to Scoop Up on Discount
Via InvestorPlace
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in August
Via The Motley Fool
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
Via Talk Markets
Topics Stocks
Exposures US Equities
The 7 Best Under $20 Stocks to Buy in August 2024
Via InvestorPlace
Kenvue (KVUE) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Kenvue News: Why Investors Are Loving KVUE Stock This Week
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.